Ljubljana, Slovenia

Marjetka Podobnik

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Prozymex A/s. Active years: 2010.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marjetka Podobnik: Innovator in Dipeptidyl Peptidase I Research

Introduction

Marjetka Podobnik is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of biochemistry, particularly in the study of dipeptidyl peptidase I (DPPI) proteins. Her innovative work has led to advancements in understanding the structure and function of these important enzymes.

Latest Patents

Marjetka Podobnik holds a patent for her invention titled "Dipeptidyl peptidase I crystal structure and its uses." This patent relates to structural studies of DPPI proteins, including modified versions and their co-complexes. The invention includes a crystal of DPPI and structural information obtained through X-ray crystallography from both rat and human sources. Furthermore, her work provides methods for utilizing the structural coordinates of DPPI and its mutants to design compounds that can bind to the active site or accessory binding sites, as well as to develop improved inhibitors of DPPI.

Career Highlights

Throughout her career, Marjetka has worked with notable organizations, including Prozymex A/S and the University of Ljubljana. Her research has been instrumental in advancing the understanding of DPPI and its potential applications in therapeutic contexts.

Collaborations

Marjetka has collaborated with esteemed colleagues such as John Pedersen and Igor Stern, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Marjetka Podobnik's innovative research and patent contributions have significantly impacted the study of dipeptidyl peptidase I. Her work continues to pave the way for future advancements in biochemistry and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…